Literature DB >> 21561906

Gammaretroviral integration into nucleosomal target DNA in vivo.

Shoshannah L Roth1, Nirav Malani, Frederic D Bushman.   

Abstract

Some of the earliest studies of retroviral integration targeting reported that sites of gammaretroviral DNA integration were positively correlated with DNase I-hypersensitive sites in chromatin. This led to the suggestion that open chromatin was favorable for integration. More recent deep sequencing experiments confirmed that gammaretroviral integration sites and DNase I cleavage sites are associated in genome-wide surveys. Paradoxically, in vitro studies of integration show that nucleosomal DNA is actually favored over naked DNA, raising the question of whether integration target DNA in chromosomes is wrapped in nucleosomes or nucleosome free. In this study we examined gammaretroviral integration by infecting primary human CD4(+) T lymphocytes with a murine leukemia virus (MLV)-based retroviral vector or xenotropic murine leukemia virus-related virus (XMRV), and isolated 32,585 unique integration sites using ligation-mediated PCR and 454 pyrosequencing. CD4(+) T lymphocytes were chosen for study because of the particularly dense genome-wide mapping of chromatin features available for comparison. Analysis relative to predicted nucleosome positions showed that gammaretroviruses direct integration into outward-facing major grooves on nucleosome-wrapped DNA, similar to the integration pattern of HIV. Also, a suite of histone modifications correlated with gene activity are positively associated with integration by both MLV and XMRV. Thus, we conclude that favored integration near DNase I-hypersensitive sites does not imply that integration takes place exclusively in nucleosome-free regions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561906      PMCID: PMC3126552          DOI: 10.1128/JVI.00635-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  A genomic code for nucleosome positioning.

Authors:  Eran Segal; Yvonne Fondufe-Mittendorf; Lingyi Chen; AnnChristine Thåström; Yair Field; Irene K Moore; Ji-Ping Z Wang; Jonathan Widom
Journal:  Nature       Date:  2006-07-19       Impact factor: 49.962

Review 2.  Chromatin crosstalk in development and disease: lessons from REST.

Authors:  Lezanne Ooi; Ian C Wood
Journal:  Nat Rev Genet       Date:  2007-07       Impact factor: 53.242

3.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

4.  An essential role for LEDGF/p75 in HIV integration.

Authors:  Manuel Llano; Dyana T Saenz; Anne Meehan; Phonphimon Wongthida; Mary Peretz; William H Walker; Wulin Teo; Eric M Poeschla
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

5.  Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.

Authors:  Peter Cherepanov; Andre L B Ambrosio; Shaila Rahman; Tom Ellenberger; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

6.  A role for LEDGF/p75 in targeting HIV DNA integration.

Authors:  Angela Ciuffi; Manuel Llano; Eric Poeschla; Christian Hoffmann; Jeremy Leipzig; Paul Shinn; Joseph R Ecker; Frederic Bushman
Journal:  Nat Med       Date:  2005-11-27       Impact factor: 53.440

7.  The influence of DNA and nucleosome structure on integration events directed by HIV integrase.

Authors:  D Pruss; R Reeves; F D Bushman; A P Wolffe
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

8.  A method to sequence and quantify DNA integration for monitoring outcome in gene therapy.

Authors:  Troy Brady; Shoshannah L Roth; Nirav Malani; Gary P Wang; Charles C Berry; Philippe Leboulch; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo; Eirini P Papapetrou; Michel Sadelain; Harri Savilahti; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2011-03-16       Impact factor: 16.971

9.  Retroviral DNA integration: viral and cellular determinants of target-site selection.

Authors:  Mary K Lewinski; Masahiro Yamashita; Michael Emerman; Angela Ciuffi; Heather Marshall; Gregory Crawford; Francis Collins; Paul Shinn; Jeremy Leipzig; Sridhar Hannenhalli; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

10.  Selection of target sites for mobile DNA integration in the human genome.

Authors:  Charles Berry; Sridhar Hannenhalli; Jeremy Leipzig; Frederic D Bushman
Journal:  PLoS Comput Biol       Date:  2006-11-24       Impact factor: 4.475

View more
  47 in total

1.  Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.

Authors:  Christian M Brommel; Ashley L Cooney; Patrick L Sinn
Journal:  Hum Gene Ther       Date:  2020-08-21       Impact factor: 5.695

2.  The frustrated gene: origins of eukaryotic gene expression.

Authors:  Hiten D Madhani
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

3.  Prototypic chromatin insulator cHS4 protects retroviral transgene from silencing in Schistosoma mansoni.

Authors:  Sutas Suttiprapa; Gabriel Rinaldi; Paul J Brindley
Journal:  Transgenic Res       Date:  2011-09-15       Impact factor: 2.788

4.  GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture.

Authors:  Anne Bruggemans; Gerlinde Vansant; Mini Balakrishnan; Michael L Mitchell; Ruby Cai; Frauke Christ; Zeger Debyser
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

5.  Enhancers are major targets for murine leukemia virus vector integration.

Authors:  Suk See De Ravin; Ling Su; Narda Theobald; Uimook Choi; Janet L Macpherson; Michael Poidinger; Geoff Symonds; Susan M Pond; Andrea L Ferris; Stephen H Hughes; Harry L Malech; Xiaolin Wu
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Retrotransposon Ty1 integration targets specifically positioned asymmetric nucleosomal DNA segments in tRNA hotspots.

Authors:  Loris Mularoni; Yulian Zhou; Tyson Bowen; Sunil Gangadharan; Sarah J Wheelan; Jef D Boeke
Journal:  Genome Res       Date:  2012-01-04       Impact factor: 9.043

7.  A nucleosomal surface defines an integration hotspot for the Saccharomyces cerevisiae Ty1 retrotransposon.

Authors:  Joshua A Baller; Jiquan Gao; Radostina Stamenova; M Joan Curcio; Daniel F Voytas
Journal:  Genome Res       Date:  2012-01-04       Impact factor: 9.043

8.  Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites.

Authors:  Erik Serrao; Peter Cherepanov; Alan N Engelman
Journal:  J Vis Exp       Date:  2016-03-22       Impact factor: 1.355

9.  Key determinants of target DNA recognition by retroviral intasomes.

Authors:  Erik Serrao; Allison Ballandras-Colas; Peter Cherepanov; Goedele N Maertens; Alan N Engelman
Journal:  Retrovirology       Date:  2015-04-30       Impact factor: 4.602

Review 10.  Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Authors:  Perry B Hackett; David A Largaespada; Kirsten C Switzer; Laurence J N Cooper
Journal:  Transl Res       Date:  2013-01-10       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.